Plain-English translation of NCT06016855 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a new treatment approach for people with neuroendocrine tumors (slow-growing cancers) that have spread to the liver. The study combines surgery to remove large tumors with a targeted radiation treatment called . Researchers want to see if doing surgery first helps the radiation treatment work better and is safe for patients.
Current treatments for these tumors don't always work as well as doctors hope. This trial is exploring whether removing the largest tumors surgically before giving the radiation treatment could help more patients respond to therapy and live longer.
You likely qualify if…
You likely don't qualify if…
You would have surgery on day 1 to remove large tumors, then receive the targeted radiation treatment as an IV infusion starting the next day. The radiation treatment is given every 8 weeks for up to 4 rounds. Throughout the study, you'll have imaging scans (CT, MRI, and PET scans) to check how your tumors are responding. After finishing treatment, you'll be followed up with visits at 1 month and then every 3 months for 2 years to monitor your health.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States